Literature DB >> 20224314

AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.

Dustyn E Williams1, Minolfa C Prieto, John J Mullins, L Gabriel Navar, Kenneth D Mitchell.   

Abstract

INTRODUCTION: This study was performed to determine the effects of high-salt diet on the magnitude of the increases in systolic blood pressure (SBP) and kidney tissue angiotensin (ANG) II levels that occur after induction of ANG II-dependent malignant hypertension in Cyp1a1-Ren2 transgenic rats with inducible expression of the mouse Ren2 renin gene [strain name: TGR(Cyp1a1Ren2)].
METHODS: Cyp1a1-Ren2 rats (n = 6) were fed a normal diet containing 0.3% indole-3-carbinol (I3C) for 10 days to induce ANG II-dependent malignant hypertension.
RESULTS: Rats induced with I3C exhibited increases in SBP and elevations of ANG II levels in kidney cortex and medulla. In a second group of rats (n = 6), high-salt intake alone did not alter basal SBP; however, subsequent dietary administration of 0.3% I3C during continued high-salt intake elicited a substantially greater increase in SBP than observed in rats fed a normal salt diet. ANG II levels in kidney cortex and medulla of rats induced with I3C and fed a high-salt diet were elevated similarly to those in rats induced with I3C alone. Chronic administration of the AT1 receptor antagonist, losartan (100 mg/L in drinking water, n = 6), markedly attenuated the I3C-induced increase in SBP and prevented the augmentation of ANG II levels in kidney cortex and medulla in rats induced with I3C and maintained on a high-salt diet.
CONCLUSIONS: Activation of AT1 receptors contributes to the augmented blood pressure and elevated kidney tissue ANG II levels that occur in Cyp1a1-Ren2 transgenic rats with malignant hypertension maintained on a high-salt diet.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224314      PMCID: PMC2880537          DOI: 10.1097/MAJ.0b013e3181d2b0a8

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  31 in total

1.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

2.  Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease.

Authors:  S Kantachuvesiri; S Fleming; J Peters; B Peters; G Brooker; A G Lammie; I McGrath; Y Kotelevtsev; J J Mullins
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

3.  Dysregulation of angiotensin II synthesis is associated with salt sensitivity in the spontaneous hypertensive rat.

Authors:  G Hodge; V Z C Ye; K A Duggan
Journal:  Acta Physiol Scand       Date:  2002-03

4.  Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet.

Authors:  Hiroyuki Kobori; Akira Nishiyama; Youichi Abe; L Gabriel Navar
Journal:  Hypertension       Date:  2003-02-10       Impact factor: 10.190

5.  Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension.

Authors:  Xueying Zhao; David M Pollock; Edward W Inscho; Darryl C Zeldin; John D Imig
Journal:  Hypertension       Date:  2002-12-16       Impact factor: 10.190

6.  Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants.

Authors:  W D Loub; L W Wattenberg; D W Davis
Journal:  J Natl Cancer Inst       Date:  1975-04       Impact factor: 13.506

7.  Responsiveness vs. basal activity of plasma ANG II as a determinant of arterial pressure salt sensitivity.

Authors:  John W Osborn; Pilar Ariza-Nieto; John P Collister; Sandra Soucheray; Benjamin Zimmerman; Stephen Katz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-24       Impact factor: 4.733

8.  Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension.

Authors:  Hiroyuki Kobori; Akira Nishiyama; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

9.  AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Minolfa C Prieto-Carrasquero; Yuri Ozawa; L Gabriel Navar
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190

10.  Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases.

Authors:  Xueying Zhao; David M Pollock; Darryl C Zeldin; John D Imig
Journal:  Hypertension       Date:  2003-08-04       Impact factor: 10.190

View more
  13 in total

1.  Attenuated renal vascular responses to acute angiotensin II infusion in smooth muscle-specific Na+/Ca2+ exchanger knockout mice.

Authors:  Di Zhao; Jin Zhang; Mordecai P Blaustein; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-22

2.  Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats.

Authors:  Zuzana Honetschlägerová; Alexandra Sporková; Libor Kopkan; Zuzana Husková; Sung H Hwang; Bruce D Hammock; John D Imig; Herbert J Kramer; Petr Kujal; Zdenka Vernerová; Věra C Chábová; Vladimír Tesař; Luděk Cervenka
Journal:  J Hypertens       Date:  2011-08       Impact factor: 4.844

3.  Chronic direct renin inhibition with aliskiren prevents the development of hypertension in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent hypertension.

Authors:  Lily Huang; Catherine G Howard; Kenneth D Mitchell
Journal:  Am J Med Sci       Date:  2012-10       Impact factor: 2.378

Review 4.  Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms.

Authors:  Dewan S A Majid; Minolfa C Prieto; Luis Gabriel Navar
Journal:  Curr Hypertens Rev       Date:  2015

5.  AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension.

Authors:  Lucienne S Lara; Michael McCormack; Laura C Semprum-Prieto; Sylvia Shenouda; Dewan S A Majid; Hiroyuki Kobori; L Gabriel Navar; Minolfa C Prieto
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-07

6.  Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.

Authors:  Miguel L Graciano; Kenneth D Mitchell
Journal:  Am J Physiol Renal Physiol       Date:  2011-10-05

7.  Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.

Authors:  Catherina A Cuevas; Alexis A Gonzalez; Nibaldo C Inestrosa; Carlos P Vio; Minolfa C Prieto
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-19

8.  Renal functional responses to selective intrarenal renin inhibition in Cyp1a1-Ren2 transgenic rats with ANG II-dependent malignant hypertension.

Authors:  Catherine G Howard; Kenneth D Mitchell
Journal:  Am J Physiol Renal Physiol       Date:  2011-10-12

9.  Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.

Authors:  Minolfa C Prieto; Dustyn E Williams; Liu Liu; Kimberly L Kavanagh; John J Mullins; Kenneth D Mitchell
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-10

10.  Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension.

Authors:  Vicky F Rands; Dale M Seth; Hiroyuki Kobori; Minolfa C Prieto
Journal:  Gend Med       Date:  2012-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.